Amarin | AMRN - Ebit





Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
DBV Technologies USD -34.28M 6.83M 2025-09
Esperion Therapeutics USD 85.23M 95.19M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12